A Study of RoActemra/Actemra (Tocilizumab) in Patients With Ankylosing Spondylitis Who Have Failed Treatment With NSAIDs

NCT01209702 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

306

Enrollment

INDUSTRY

Sponsor class

Stopped Recruitment halted: Failed to achieve efficacy

Conditions

Spondylitis, Ankylosing

Interventions

BIOLOGICAL: tocilizumab
DRUG: Placebo

Sponsor

Hoffmann-La Roche